CLASS II ONGOING Device recall · Reported 28 Aug 2024 · FDA Enforcement Report

Biofire Filmarray Pneumonia Panel recalled by BioFire Diagnostics

BioFire Diagnostics is recalling Biofire Filmarray Pneumonia Panel, distributed nationwide in the US. The recall was initiated on 10 Jun 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 00815381020178. Lot/Expiration: 2147623/28-Aug-2024, 2147523/27-Aug-2024
Quantity recalled58

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2682-2024
FDA event ID
94942
Recalling firm
BioFire Diagnostics, Salt Lake City, UT
Classification
Class II
Status
Ongoing
Recall initiated
10 Jun 2024
FDA classified
16 Aug 2024
Reported
28 Aug 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Lead & Heavy Metals

Timeline

10 Jun 2024Recall initiated by company
16 Aug 2024Classified by FDA+67 days
28 Aug 2024Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Pneumonia panels have an increased risk of control failures due to an issue in the manufacturing process, which could lead to delayed results for the customer.

Lead and other heavy metals accumulate in the body. Children are most at risk; even low levels can affect development.

Product as listed by the FDA

BIOFIRE FILMARRAY Pneumonia Panel, REF: RFIT-ASY-0144

Where it was distributed

Worldwide - US Nationwide distribution in the states of WV, IN, AL and the countries of France, Italia, Spain, Greece, Japan Ltd, Singapore, Chile, Taiwan, Israel, Romania, Ecuador, Serbia.

Nationwide AlabamaIndianaWest Virginia

Questions about this recall

Is Biofire Filmarray Pneumonia Panel recalled?

Yes. BioFire Diagnostics recalled Biofire Filmarray Pneumonia Panel on 10 Jun 2024. The recall is Class II and its status is Ongoing. Recall number Z-2682-2024.

Why was it recalled?

Pneumonia panels have an increased risk of control failures due to an issue in the manufacturing process, which could lead to delayed results for the customer.

Which lots are affected?

UDI-DI: 00815381020178. Lot/Expiration: 2147623/28-Aug-2024, 2147523/27-Aug-2024

Where was it sold?

Worldwide - US Nationwide distribution in the states of WV, IN, AL and the countries of France, Italia, Spain, Greece, Japan Ltd, Singapore, Chile, Taiwan, Israel, Romania, Ecuador, Serbia.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from BioFire Diagnostics

All 44

Other Other Medical Devices recalls

All 13,778